Chief Operating Officer

Healx

Kate has always been driven to make a difference in patients’ lives, from her early academic research at Oxford and Harvard Universities, to leading drug discovery teams and organisations in industry. Prior to joining Healx, Kate was Corporate VP at Charles River Discovery, leading a team of over 400 drug discovery scientists in three countries. The client base was worldwide and under her leadership the organization delivered on average 3-4 preclinical drug candidates per year for its partners. Her 25+ years’ industry experience includes senior leadership positions at Cambridge Antibody Technology as Director of Discovery Biology and Roche as Head of Inflammatory Diseases.

Latest insights

Fri Mar 13 2020

Did an experimental drug help a U.S. coronavirus patient?

Fri Jan 10 2020

MoneyBall Medicine: Tom Davenport on the Analytics Gap in Healthcare

Wed Dec 18 2019

MoneyBall Medicine – Milind Kamkolkar on Seeing the Forest and the Tr...

Fri Nov 8 2019

Gini Deshpande of NuMedii on Augmented Intelligence for Drug Discovery

Never miss an announcement